| CAS ID: | 137234-62-9 |
| Molecular Formula: | C16H14F3N5O |
| Molecular Weight: | 349.3 g/mol |
| Monoisotopic Mass: | 349.115 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | VORICONAZOLE | VFEND | UK-109,496 |
| Analysis: | Drug repositioning mechanism analysis |
| Target ID | Name | Interaction |
|---|---|---|
| T0464 | Cytochrome P450 3A4 | Other Interaction |
Reference Record 1
Trial Record 1
| ClinicalTrial ID | NCT01576315 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | April 12, 2012 | Last Verified | April 12, 2016 |
| Sponsor | Rennes University Hospital | ||